{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:01:15Z","timestamp":1790726475438,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40259-024-00699-6","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T02:02:23Z","timestamp":1739239343000},"page":"321-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization Study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-8280","authenticated-orcid":false,"given":"Nadia","family":"Haddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8035-7517","authenticated-orcid":false,"given":"Hugo","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-3867","authenticated-orcid":false,"given":"David","family":"Desplas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4115-7093","authenticated-orcid":false,"given":"Marion","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-7759","authenticated-orcid":false,"given":"Marie-Joelle","family":"Jabagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5393-5406","authenticated-orcid":false,"given":"Claire","family":"Rives-Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8393-4217","authenticated-orcid":false,"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"4","key":"699_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"24","key":"699_CR2","first-page":"00334","volume":"S0002\u20139343","author":"R Spector","year":"2024","unstructured":"Spector R. A revolution in the treatment of obesity. Am J Med. 2024;S0002\u20139343(24):00334\u20136.","journal-title":"Am J Med"},{"issue":"6","key":"699_CR3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/oby.22794","volume":"28","author":"RF Kushner","year":"2020","unstructured":"Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B, et al. Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity (Silver Spring). 2020;28(6):1050\u201361.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"699_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/dom.12824","volume":"19","author":"K Bettge","year":"2017","unstructured":"Bettge K, Kahle M, Abd El Aziz MS, Meier JJ, Nauck MA. Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials. Diabetes Obes Metab. 2017;19(3):336\u201347.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"699_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1001\/jama.2021.23619","volume":"327","author":"DM Rubino","year":"2022","unstructured":"Rubino DM, Greenway FL, Khalid U, O\u2019Neil PM, Rosenstock J, S\u00f8rrig R, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA. 2022;327(2):138.","journal-title":"JAMA"},{"issue":"7","key":"699_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","volume":"173","author":"S Singh","year":"2013","unstructured":"Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013;173(7):534.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"699_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/dom.14551","volume":"24","author":"S Wharton","year":"2022","unstructured":"Wharton S, Calanna S, Davies M, Dicker D, Goldman B, Lingvay I, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94\u2013105.","journal-title":"Diabetes Obes Metab"},{"issue":"24","key":"699_CR8","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221\u201332.","journal-title":"N Engl J Med"},{"issue":"10437","key":"699_CR9","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","volume":"403","author":"J Butler","year":"2024","unstructured":"Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstr\u00f8m SZ, Davies MJ, et al. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet. 2024;403(10437):1635\u201348.","journal-title":"Lancet"},{"key":"699_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078078","volume":"27","author":"N Roland","year":"2024","unstructured":"Roland N, Neumann A, Hoisnard L, Duranteau L, Froelich S, Zureik M, et al. Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ. 2024;27: e078078.","journal-title":"BMJ"},{"issue":"2","key":"699_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/13524585231223395","volume":"30","author":"M Swital","year":"2024","unstructured":"Swital M, Drouin J, Miranda S, Bakchine S, Botton J, Dray-Spira R. Use of multiple sclerosis disease-modifying therapies during pregnancy in France: nationwide study between 2010 and 2021. Mult Scler. 2024;30(2):227\u201337.","journal-title":"Mult Scler"},{"issue":"Suppl. 4","key":"699_CR12","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","volume":"65","author":"P Tuppin","year":"2017","unstructured":"Tuppin P, Rudant J, Constantinou P, Gastaldi-M\u00e9nager C, Rachas A, de Roquefeuil L, et al. Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65(Suppl. 4):S149\u201367.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"9","key":"699_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/MLR.0000000000001745","volume":"60","author":"A Rachas","year":"2022","unstructured":"Rachas A, Gastaldi-M\u00e9nager C, Denis P, Barth\u00e9l\u00e9my P, Constantinou P, Drouin J, et al. The economic burden of disease in France from the national health insurance perspective: the healthcare expenditures and conditions mapping used to prepare the French Social Security Funding Act and the Public Health Act. Med Care. 2022;60(9):655\u201364.","journal-title":"Med Care"},{"key":"699_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssresearch.2022.102772","volume":"107","author":"TF Liao","year":"2022","unstructured":"Liao TF, Bolano D, Brzinsky-Fay C, Cornwell B, Fasang AE, Helske S, et al. Sequence analysis: its past, present, and future. Soc Sci Res. 2022;107: 102772.","journal-title":"Soc Sci Res"},{"issue":"2","key":"699_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/rssa.12125","volume":"179","author":"M Studer","year":"2016","unstructured":"Studer M, Ritschard G. What matters in differences between life trajectories: a comparative review of sequence dissimilarity measures. J Royal Stat Soc A. 2016;179(2):481\u2013511.","journal-title":"J Royal Stat Soc A."},{"issue":"4","key":"699_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.chest.2022.10.008","volume":"163","author":"GL Martin","year":"2023","unstructured":"Martin GL, Atramont A, Mazars M, Tajahmady A, Agamaliyev E, Singer M, et al. Days spent at home and mortality after critical illness: a cluster analysis using nationwide data. Chest. 2023;163(4):826\u201342.","journal-title":"Chest"},{"issue":"4","key":"699_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.18637\/jss.v040.i04","volume":"40","author":"A Gabadinho","year":"2011","unstructured":"Gabadinho A, Ritschard G, M\u00fcller NS, Studer M. Analyzing and visualizing state sequences in R with TraMineR. J Stat Soft. 2011;40(4):147.","journal-title":"J Stat Soft"},{"issue":"3","key":"699_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/jcm12030925","volume":"12","author":"A Fontbonne","year":"2023","unstructured":"Fontbonne A, Currie A, Tounian P, Picot MC, Foulatier O, Nedelcu M, et al. Prevalence of overweight and obesity in France: the 2020 Obepi-Roche Study by the \u201cLigue Contre l\u2019Ob\u00e9sit\u00e9.\u201d J Clin Med. 2023;12(3):925.","journal-title":"J Clin Med"},{"issue":"49","key":"699_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005314","volume":"95","author":"S Czernichow","year":"2016","unstructured":"Czernichow S, Paita M, Nocca D, Msika S, Basdevant A, Millat B, et al. Current challenges in providing bariatric surgery in France: a nationwide study. Medicine (Baltimore). 2016;95(49): e5314.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"699_CR20","first-page":"1","volume":"17","author":"K Chevreul","year":"2015","unstructured":"Chevreul K, Berg Brigham K, Durand-Zaleski I, Hernandez-Quevedo C. France: health system review. Health Syst Transit. 2015;17(3):1\u2013218 (xvii).","journal-title":"Health Syst Transit"},{"issue":"2","key":"699_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40618-023-02196-z","volume":"47","author":"G Muscogiuri","year":"2024","unstructured":"Muscogiuri G, Verde L, Vetrani C, Barrea L, Savastano S, Colao A. Obesity: a gender-view. J Endocrinol Invest. 2024;47(2):299\u2013306.","journal-title":"J Endocrinol Invest"},{"issue":"2S","key":"699_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jviscsurg.2022.12.004","volume":"160","author":"A Lazzati","year":"2023","unstructured":"Lazzati A. Epidemiology of the surgical management of obesity. J Visc Surg. 2023;160(2S):S3-6.","journal-title":"J Visc Surg"},{"issue":"3","key":"699_CR23","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s00464-017-5819-z","volume":"32","author":"J Kochkodan","year":"2018","unstructured":"Kochkodan J, Telem DA, Ghaferi AA. Physiologic and psychological gender differences in bariatric surgery. Surg Endosc. 2018;32(3):1382\u20138.","journal-title":"Surg Endosc"},{"issue":"2","key":"699_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.soard.2013.07.015","volume":"10","author":"A Lazzati","year":"2014","unstructured":"Lazzati A, Guy-Lachuer R, Delaunay V, Szwarcensztein K, Azoulay D. Bariatric surgery trends in France: 2005\u20132011. Surg Obes Relat Dis. 2014;10(2):328\u201334.","journal-title":"Surg Obes Relat Dis."},{"issue":"9","key":"699_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.7326\/M22-0160","volume":"175","author":"AG Cantor","year":"2022","unstructured":"Cantor AG, Nelson HD, Pappas M, Atchison C. Preventing obesity in midlife women: a systematic review for the Women\u2019s Preventive Services Initiative. Ann Intern Med. 2022;175(9):1275\u201384.","journal-title":"Ann Intern Med"},{"issue":"1","key":"699_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","volume":"134","author":"S Wharton","year":"2022","unstructured":"Wharton S, Davies M, Dicker D, Lingvay I, Mosenzon O, Rubino DM, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134(1):14\u20139.","journal-title":"Postgrad Med"},{"issue":"11","key":"699_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002.","journal-title":"N Engl J Med"},{"issue":"11","key":"699_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S2213-8587(23)00232-2","volume":"11","author":"L Szczerbinski","year":"2023","unstructured":"Szczerbinski L, Florez JC. Precision medicine of obesity as an integral part of type 2 diabetes management: past, present, and future. Lancet Diabetes Endocrinol. 2023;11(11):861\u201378.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"699_CR29","doi-asserted-by":"publisher","first-page":"12387","DOI":"10.1038\/s41598-022-16260-w","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen S, Dai Y, Ma X, Peng H, Wang D, Wang Y. Personalized optimal nutrition lifestyle for self obesity management using metaalgorithms. Sci Rep. 2022;12(1):12387.","journal-title":"Sci Rep"}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-024-00699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40259-024-00699-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-024-00699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:47:21Z","timestamp":1741848441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40259-024-00699-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1007\/s40259-024-00699-6","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"10 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as part of the authors\u2019 regular employment duties at the French National Health Insurance (CNAM), the French National Agency for Medicines, and Health Products Safety (ANSM). No additional external funding was received for this specific study. As no external funding was received for this study, there were no external funders involved in the study design, data collection, analysis, interpretation, or report writing, or the decision to submit the paper for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Nadia Haddy, Hugo Jourdain, David Desplas, Marion Bertrand, Marie-Joelle Jabagi, Claire Rives-Lange, and Mahmoud Zureik have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"EPI-PHARE has permanent regulatory access to the data from the French National Health Data System (SNDS) via its constitutive bodies ANSM and CNAM, in application of the provisions of the French Decree No. 2016-1871 of 26 December, 2016 relating to the processing of personal data called the \u201cNational Health Data System\u201d 15, the French law articles Art. R. 1461-1316 and R. 1461-1417 from the French Public Health Code, and the French Data Protection Authority (CNIL) decision CNIL-2016-316.18. In accordance with the permanent regulatory access granted to EPI-PHARE via ANSM and CNAM, this work did not require any specific opinion from the French Ethical and Scientific Committee for Research, Studies and Evaluations health (CESREES) nor approval from the CNIL. All requests in the database were made by duly authorized people. The study was registered on the study register of EPI-PHARE concerning studies from SNDS data under the reference T-2023-12-488.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The French National Health Data System (SNDS) is a strictly anonymous database set, including all mandatory health insurance reimbursement data of the French population, in particular data from the processing of healthcare reimbursements (electronic or paper treatment sheet) and data from health establishments (PMSI). In accordance with data protection legislation and the French regulation, the authors are not allowed to release or make public the data from the SNDS. However, any person or structure, public or private, for-profit or non-profit is able to access SNDS data in order to carry out a study, research, or an evaluation in the public interest, upon authorization from the French Data Protection Office (CNIL), via the French Health Data Hub (). All information for the data subject is available on the EPI-PHARE website at .","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Literature search: NH, HJ, CRL. Study design: NH, HJ. Data extraction and collection: HJ and DD. Statistical analysis: HJ. Interpretation of the results: NH, CRL, HJ. Drafting of the manuscript: NH, CRL, HJ. Revision of the manuscript: all. Supervision: NH and MZ. HJ, NH, and MZ confirm that they had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. HJ, NH, and MZ had final responsibility for the decision to submit the manuscript for publication.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}